MICROFLEB
MICROFLEB 30 TABLETS
MICROFLEB 30 TABLETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
Microfleb
Food supplement, indicated as an adjuvant to microcirculation.
Ingredients
| per 1 tablet | |
| Troxerutin | 300 mg |
| Hesperidin | 100 mg |
| Melilot* dry extract 20% *coumarin intake |
37.6 mg 7.52 mg |
| Other ingredients: calcium phosphate dibasic; vegetable magnesium stearate; silicon dioxide. | |
How to use
We recommend taking 1 tablet per day, with a sip of water, after one of the main meals.
Warnings
Do not take during pregnancy and breastfeeding.
Keep out of reach of children under 3 years.
Do not exceed the recommended daily dose.
Supplements should not be used as a substitute for a varied diet.
For children, it is recommended to seek medical advice.
Conservation
Store below 30°C and away from direct sources of heat and humidity.
Shelf life in unopened packaging: 36 months.
Format
Case containing 2 blisters of 15 tablets.
MICROFLEB
MICROFLEB 30 TABLETS
MICROFLEB 30 TABLETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
